Tubica Tablets 5/20 Milligrams

Adult dose

This medication should be administered once daily, 1 tablet, with water regardless of meals. It is recommended to take it at the same time daily (e.g., in the morning) if possible. The recommended dosages are as follows: - 5/20 milligrams: administered to patients whose blood pressure is not adequately controlled with monotherapy of amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams. - 10/20 milligrams: administered to patients whose blood pressure is not adequately controlled with monotherapy of olmesartan medoxomil 20 milligrams.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established.

This medication can cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Persons who are allergic to this drug's active ingredients or dihydropyridine derivatives, those who are pregnant or breastfeeding, patients with severe liver dysfunction, aortic stenosis, bile duct obstruction, those undergoing kidney dialysis, patients in shock, and certain diabetic patients should not take this medication. Patients with hypotension due to fluid or salt depletion, patients with severe vascular dilation, severe obstructive coronary artery disease, congestive heart failure, kidney impairment, and liver impairment should be closely monitored while taking this medication. While taking this medication, adverse reactions such as dizziness, headache, hypotension, palpitations, dyspepsia, rash, and edema may occur, and if symptoms are severe, a consultation with medical personnel is advised. Unlike when abruptly stopping beta-blockers, while this drug is not a beta-blocker, the dose should be tapered slowly if discontinuing beta-blocker therapy. There may be interactions when taken with other antihypertensives, diuretics, antibiotics, or grapefruit juice, so all medications being taken should be reported to medical personnel. This medication should not be taken during pregnancy, and if planning to become pregnant, it is advisable to switch to other treatments with proven safety instead of this medication. During breastfeeding, this medication may be passed into breast milk and cause adverse reactions in infants, so it is recommended to either stop breastfeeding or discontinue this medication. This medication is not recommended for patients under 18 years of age, as safety and efficacy have not been established. Elderly patients may have decreased kidney and liver function, so the dose should be carefully adjusted, and attention to adverse effects is necessary. In the event of an overdose, symptoms such as hypotension and increased heart rate may occur, so if suspected, immediate medical attention is necessary. This medication should be stored out of the reach of children, in a tightly sealed container to prevent exposure to air or moisture, and should be kept away from direct sunlight, humidity, and heat; it is also safe not to transfer to another container.

Serious side effects

• Urticaria
• cholelithiasis
• neoplasm of female breast
• exacerbation of cerebral infarction
• gum bleeding
• syncope
• shortness of breath
• angioedema
• alopecia
• high fever and severe rash

Mild side effects

• Decreased libido
• dizziness
• headache
• orthostatic hypotension
• drowsiness
• abnormal sensation
• decreased sensation
• lightheadedness
• palpitations
• rapid heartbeat

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, it is advisable to store the medication at room temperature between 1 to 30 degrees Celsius, avoiding excessively hot or cold places.

Appearance

White round film-coated tablet

Package unit

28 tablets (14 tablets/PTP x 2)